Risk of Bleeding and Thrombosis in Patients 70 Years or Older Using Vitamin K Antagonists | Zendy

Hilde Kooistra | Zendy; Agneta Calf | Zendy; Margriet PiersmaWichers | Zendy; Hanneke C. KluinNelemans | Zendy; Gerbrand J. Izaks | Zendy; Nic J.G.M. Veeger | Zendy; Karina Meijer | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Risk of Bleeding and Thrombosis in Patients 70 Years or Older Using Vitamin K Antagonists

Author(s) -

Hilde Kooistra,

Agneta Calf,

Margriet PiersmaWichers,

Hanneke C. KluinNelemans,

Gerbrand J. Izaks,

Nic J.G.M. Veeger,

Karina Meijer

Publication year - 2016

Publication title -

jama internal medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.14

H-Index - 342

eISSN - 2168-6114

pISSN - 2168-6106

DOI - 10.1001/jamainternmed.2016.3057

Subject(s) - medicine , vitamin k antagonist , thrombosis , hazard ratio , major bleeding , cohort , cohort study , surgery , pediatrics , warfarin , confidence interval , myocardial infarction , atrial fibrillation

Previous studies have shown that, despite the higher risk of bleeding, the elderly still benefit from taking anticoagulants if they have a stringent indication. However, owing to the relatively low number of patients older than 90 years in these studies, it is unknown whether this benefit is also seen with the eldest patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research